Focus on Targeting MET Alterations in Advanced NSCLC: A Webinar for Asian Physicians

Release date: 16-08-2023

Expiration date: 16-08-2024

Optimizing the approaches to detect MET alterations in advanced NSCLC: The role of NGS-based molecular testing

Yasushi Yatabe, MD, PhD

Yasushi Yatabe, MD, PhD

National Cancer Center

Tokyo, Japan

Download Slides
  • Optimizing the approaches to detect MET alterations in advanced NSCLC: The role of NGS-based molecular testing

    Yasushi Yatabe, MD, PhD

  • Panel Discussion: Clinical insights of MET alterations detection

  • Evolving treatment options of MET exon 14 skipping in advanced NSCLC

    Myung-Ju Ahn, MD

  • Panel Discussion: Clinical insights of MET exon 14 skipping in advanced NSCLC

  • How I treat MET exon 14 skipping patients?

    Chien-Chung Lin, MD, PhD

  • Panel Discussion: Clinical Practice Advice from Experts

  • Optional strategies to overcome osimertinib resistance with MET amplification

    Nick Pavlakis, MBBS, MMEd (Clin Epi), PhD

  • Panel Discussion: Clinical insights of MET amplification after osimertinib progression

  • How I treat osimertinib resistant patients with MET amplification?

    Molly SC Li, MBBS, MRCP, FHKCP, FHKAM

  • Panel Discussion: Clinical Practice Advice from Experts

  • Pearls for Practice

    Daniel S.W. Tan, MBBS, MRCP, PhD, FAMS

Complete activity
Evaluate This Activity